X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4837) 4837
Book Review (840) 840
Publication (128) 128
Newsletter (119) 119
Magazine Article (81) 81
Book Chapter (15) 15
Newspaper Article (12) 12
Transcript (12) 12
Book / eBook (7) 7
Conference Proceeding (6) 6
Trade Publication Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
niacin (3314) 3314
humans (2571) 2571
index medicus (2136) 2136
nicotinic acids - therapeutic use (2057) 2057
old medline (1956) 1956
tuberculosis (1470) 1470
niacin - therapeutic use (1380) 1380
isoniazid (1230) 1230
isomerism (942) 942
male (911) 911
female (755) 755
tuberculosis, pulmonary - therapy (719) 719
hypolipidemic agents - therapeutic use (690) 690
middle aged (589) 589
cholesterol (514) 514
animals (511) 511
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (462) 462
abridged index medicus (455) 455
pharmacology & pharmacy (455) 455
adult (447) 447
streptomycin - therapeutic use (432) 432
drug therapy, combination (427) 427
risk factors (420) 420
atherosclerosis (415) 415
cholesterol, hdl - blood (396) 396
extended-release niacin (390) 390
aged (362) 362
cholesterol, ldl - blood (351) 351
cardiac & cardiovascular systems (332) 332
coronary-heart-disease (330) 330
aminosalicylic acid - therapeutic use (328) 328
niacin - administration & dosage (322) 322
niacin - adverse effects (306) 306
statins (306) 306
niacin - pharmacology (305) 305
anticholesteremic agents - therapeutic use (303) 303
nicotinic-acid (296) 296
treatment outcome (295) 295
medicine, general & internal (282) 282
lipids (279) 279
nicotinic acids (273) 273
hyperlipidemias - drug therapy (257) 257
cardiovascular disease (253) 253
dyslipidemias - drug therapy (253) 253
drug therapy (243) 243
triglycerides - blood (237) 237
tuberculosis - therapy (230) 230
nicotinic acid (225) 225
cardiovascular diseases - prevention & control (222) 222
child (218) 218
prevention (198) 198
health aspects (186) 186
infant (184) 184
density-lipoprotein cholesterol (181) 181
hypercholesterolemia - drug therapy (180) 180
peripheral vascular disease (180) 180
dyslipidemia (179) 179
low density lipoproteins (179) 179
delayed-action preparations (177) 177
care and treatment (176) 176
research (176) 176
hypolipidemic agents - adverse effects (175) 175
rats (174) 174
cardiovascular-disease (173) 173
lipids - blood (172) 172
secondary prevention (172) 172
analysis (168) 168
high-density-lipoprotein (167) 167
hypercholesterolemia (167) 167
ezetimibe (165) 165
tuberculosis, meningeal - therapy (163) 163
clinical trials as topic (162) 162
cardiovascular (161) 161
niacin - analogs & derivatives (160) 160
cardiology (159) 159
cardiovascular diseases (159) 159
triglycerides (157) 157
therapy (154) 154
cholesterol - blood (151) 151
anti-bacterial agents (149) 149
coronary heart disease (148) 148
double-blind method (148) 148
endocrinology & metabolism (148) 148
biochemistry & molecular biology (147) 147
disease (147) 147
myocardial-infarction (147) 147
physiological aspects (141) 141
risk (134) 134
vitamin b (133) 133
hypolipidemic agents - administration & dosage (132) 132
metabolic syndrome (132) 132
medicine & public health (131) 131
mice (129) 129
coronary disease - prevention & control (127) 127
simvastatin (125) 125
diabetes (123) 123
heart-disease (118) 118
hypolipidemic agents - pharmacology (118) 118
intima-media thickness (116) 116
lipoproteins (116) 116
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4193) 4193
German (200) 200
Italian (182) 182
French (148) 148
Spanish (118) 118
Russian (79) 79
Polish (42) 42
Hungarian (21) 21
Portuguese (21) 21
Japanese (16) 16
Czech (9) 9
Swedish (9) 9
Dutch (8) 8
Bulgarian (7) 7
Chinese (7) 7
Norwegian (4) 4
Serbian (4) 4
Danish (3) 3
Romanian (3) 3
Finnish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2001, Volume 345, Issue 22, pp. 1583 - 1592
Patients with coronary disease and low high-density lipoprotein (HDL) cholesterol levels are at risk for coronary events. This study found that a combination... 
REGRESSION | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | HEPATIC LIPASE | PLASMA | CHOLESTEROL | LOW-DENSITY-LIPOPROTEIN | CARDIOVASCULAR-DISEASE | ATHEROSCLEROSIS | ARTERY DISEASE | PROGRESSION | Simvastatin - therapeutic use | beta Carotene - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Coronary Disease - mortality | Drug Interactions | Niacin - therapeutic use | Ascorbic Acid - therapeutic use | Lipids - blood | Cardiovascular Diseases - mortality | Niacin - adverse effects | Cholesterol, LDL - blood | Female | Ascorbic Acid - blood | Drug Therapy, Combination | beta Carotene - blood | Hypolipidemic Agents - adverse effects | Double-Blind Method | Vitamin E - blood | Coronary Stenosis - drug therapy | Apolipoproteins - blood | Selenium - therapeutic use | alpha-Tocopherol - therapeutic use | Coronary Angiography | Antioxidants - therapeutic use | Coronary Disease - prevention & control | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cholesterol, HDL - blood | Coronary Disease - drug therapy | Hypolipidemic Agents - therapeutic use | Evaluation | Care and treatment | Simvastatin | Atherosclerosis | Coronary heart disease | Niacin | Health aspects | Cardiovascular disease | Heart attacks | Cholesterol | Colleges & universities | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 24, pp. 2255 - 2267
In this clinical trial involving patients with established cardiovascular disease, the addition of niacin to intensive statin therapy provided no additional... 
LDL CHOLESTEROL | MEDICINE, GENERAL & INTERNAL | DENSITY-LIPOPROTEIN CHOLESTEROL | IMPACT | CARDIOVASCULAR EVENTS | ATHEROSCLEROSIS | CORONARY-HEART-DISEASE | COMBINATION | ARTERIAL BIOLOGY | EXTENDED-RELEASE NIACIN | SECONDARY PREVENTION | Simvastatin - therapeutic use | Humans | Middle Aged | Male | Niacin - therapeutic use | Treatment Failure | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Niacin - adverse effects | Cholesterol, LDL - blood | Female | Brain Ischemia - chemically induced | Muscular Diseases - chemically induced | Drug Therapy, Combination | Brain Ischemia - epidemiology | Hypolipidemic Agents - adverse effects | Atherosclerosis - drug therapy | Kaplan-Meier Estimate | Proportional Hazards Models | Atherosclerosis - blood | Medication Adherence | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cholesterol, HDL - blood | Aged | Hypolipidemic Agents - therapeutic use | Drugs | Dose-response relationship (Biochemistry) | Control | Dosage and administration | Product/Service Evaluations | Drug therapy | Niacin | Cholesterol | Statins | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Simvastatin | Cardiovascular disease | Triglycerides | Coronary artery disease | Ischemia | Diet | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Lipoproteins (high density) | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article
Chemical Communications, ISSN 1359-7345, 07/2010, Volume 46, Issue 25, pp. 4526 - 4528
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2009, Volume 361, Issue 22, pp. 2113 - 2122
Journal Article
JOURNAL OF FAMILY PRACTICE, ISSN 0094-3509, 05/2017, Volume 66, Issue 5, pp. 300 - 308
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 07/2010, Volume 30, Issue 7, pp. 1430 - 1438
OBJECTIVE—To examine the effects of treatments with niacin or anacetrapib (an inhibitor of cholesteryl ester transfer protein) on the ability of high-density... 
atherosclerosis | macrophages | ABC transporter | lipoproteins | ESTER TRANSFER PROTEIN | BLOOD-PRESSURE | APOLIPOPROTEIN-E | EXTENDED-RELEASE NIACIN/LAROPIPRANT | ABCA1-DEFICIENT MACROPHAGES | CORONARY ATHEROSCLEROSIS | ENDOTHELIAL-CELLS | DOUBLE-BLIND | PERIPHERAL VASCULAR DISEASE | INFLAMMATORY RESPONSE | HEMATOLOGY | CETP INHIBITION | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Lipoproteins - deficiency | ATP Binding Cassette Transporter, Sub-Family G, Member 1 | Lipoproteins - genetics | Cholesterol - blood | Humans | Oxazolidinones - adverse effects | Oxazolidinones - therapeutic use | Dyslipidemias - blood | Inflammation - metabolism | Anti-Inflammatory Agents - adverse effects | Niacin - therapeutic use | ATP-Binding Cassette Transporters - genetics | Time Factors | Inflammation Mediators - metabolism | Lipoproteins - metabolism | ATP-Binding Cassette Transporters - metabolism | Anti-Inflammatory Agents - therapeutic use | Niacin - adverse effects | ATP Binding Cassette Transporter 1 | Dyslipidemias - immunology | Foam Cells - metabolism | Macrophages - immunology | Hypolipidemic Agents - adverse effects | Dyslipidemias - drug therapy | Cells, Cultured | Treatment Outcome | Clinical Trials as Topic | Inflammation - immunology | Toll-Like Receptor 4 - metabolism | Mice, Knockout | Macrophages - metabolism | Animals | Cholesterol, HDL - blood | Hypolipidemic Agents - therapeutic use | Inflammation - prevention & control | Mice | Cholesterol Ester Transfer Proteins - metabolism | Index Medicus
Journal Article
Journal Article
Journal Article
European heart journal, ISSN 0195-668X, 2013, Volume 34, Issue 42, pp. 3251 - 3258
Journal Article